Mitochondrion, volume 13, issue 3, pages 199-208
Classification of mitocans, anti-cancer drugs acting on mitochondria
1
School of Medical Science, Griffith University, Southport, QLD, Australia
|
2
Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic.
|
Publication type: Journal Article
Publication date: 2013-05-01
Journal:
Mitochondrion
Quartile SCImago
Q2
Quartile WOS
Q1
Impact factor: 4.4
ISSN: 15677249, 18728278
Molecular Biology
Cell Biology
Molecular Medicine
Abstract
Mitochondria have emerged as an intriguing target for anti-cancer drugs, inherent to vast majority if not all types of tumours. Drugs that target mitochondria and exert anti-cancer activity have become a focus of recent research due to their great clinical potential (which has not been harnessed thus far). The exceptional potential of mitochondria as a target for anti-cancer agents has been reinforced by the discouraging finding that even tumours of the same type from individual patients differ in a number of mutations. This is consistent with the idea of personalised therapy, an elusive goal at this stage, in line with the notion that tumours are unlikely to be treated by agents that target only a single gene or a single pathway. This endows mitochondria, an invariant target present in all tumours, with an exceptional momentum. This train of thoughts inspired us to define a class of anti-cancer drugs acting by way of mitochondrial 'destabilisation', termed 'mitocans'. In this communication, we define mitocans (many of which have been known for a long time) and classify them into several classes based on their molecular mode of action. We chose the targets that are of major importance from the point of view of their role in mitochondrial destabilisation by small compounds, some of which are now trialled as anti-cancer agents. The classification starts with targets at the surface of mitochondria and ending up with those in the mitochondrial matrix. The purpose of this review is to present in a concise manner the classification of compounds that hold a considerable promise as potential anti-cancer drugs.
Citations by journals
|
2
4
6
8
10
12
14
|
|
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
13 publications, 7.34%
|
|
European Journal of Medicinal Chemistry
|
European Journal of Medicinal Chemistry
9 publications, 5.08%
|
|
Scientific Reports
|
Scientific Reports
6 publications, 3.39%
|
|
Mitochondrion
|
Mitochondrion
4 publications, 2.26%
|
|
Frontiers in Oncology
|
Frontiers in Oncology
3 publications, 1.69%
|
|
Cell Death and Disease
|
Cell Death and Disease
3 publications, 1.69%
|
|
Biomedicine and Pharmacotherapy
|
Biomedicine and Pharmacotherapy
3 publications, 1.69%
|
|
ChemMedChem
|
ChemMedChem
3 publications, 1.69%
|
|
Antioxidants and Redox Signaling
|
Antioxidants and Redox Signaling
2 publications, 1.13%
|
|
Biochemical Journal
|
Biochemical Journal
2 publications, 1.13%
|
|
Journal of Personalized Medicine
|
Journal of Personalized Medicine
2 publications, 1.13%
|
|
Biomedicines
|
Biomedicines
2 publications, 1.13%
|
|
Frontiers in Pharmacology
|
Frontiers in Pharmacology
2 publications, 1.13%
|
|
BioMetals
|
BioMetals
2 publications, 1.13%
|
|
BMC Cancer
|
BMC Cancer
2 publications, 1.13%
|
|
Journal of Controlled Release
|
Journal of Controlled Release
2 publications, 1.13%
|
|
Journal of Biological Chemistry
|
Journal of Biological Chemistry
2 publications, 1.13%
|
|
Bioorganic and Medicinal Chemistry Letters
|
Bioorganic and Medicinal Chemistry Letters
2 publications, 1.13%
|
|
Chemico-Biological Interactions
|
Chemico-Biological Interactions
2 publications, 1.13%
|
|
Biochimica et Biophysica Acta - Molecular Cell Research
|
Biochimica et Biophysica Acta - Molecular Cell Research
2 publications, 1.13%
|
|
Toxicology in Vitro
|
Toxicology in Vitro
2 publications, 1.13%
|
|
Biochimica et Biophysica Acta - Bioenergetics
|
Biochimica et Biophysica Acta - Bioenergetics
2 publications, 1.13%
|
|
Journal of Medicinal Chemistry
|
Journal of Medicinal Chemistry
2 publications, 1.13%
|
|
Advances in Experimental Medicine and Biology
|
Advances in Experimental Medicine and Biology
2 publications, 1.13%
|
|
Methods in Molecular Biology
|
Methods in Molecular Biology
2 publications, 1.13%
|
|
Molecular Cancer Therapeutics
|
Molecular Cancer Therapeutics
2 publications, 1.13%
|
|
Archiv der Pharmazie
|
Archiv der Pharmazie
1 publication, 0.56%
|
|
Antibiotics
|
Antibiotics
1 publication, 0.56%
|
|
Journal of Pharmacology and Experimental Therapeutics
|
Journal of Pharmacology and Experimental Therapeutics
1 publication, 0.56%
|
|
2
4
6
8
10
12
14
|
Citations by publishers
|
10
20
30
40
50
|
|
|
Elsevier
|
Elsevier
50 publications, 28.25%
|
|
Springer Nature
|
Springer Nature
32 publications, 18.08%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
22 publications, 12.43%
|
|
Wiley
|
Wiley
14 publications, 7.91%
|
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
9 publications, 5.08%
|
|
Frontiers Media S.A.
|
Frontiers Media S.A.
6 publications, 3.39%
|
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
5 publications, 2.82%
|
|
Bentham Science
|
Bentham Science
3 publications, 1.69%
|
|
American Society for Pharmacology and Experimental Therapeutics
|
American Society for Pharmacology and Experimental Therapeutics
2 publications, 1.13%
|
|
Mary Ann Liebert
|
Mary Ann Liebert
2 publications, 1.13%
|
|
Portland Press
|
Portland Press
2 publications, 1.13%
|
|
American Society for Biochemistry and Molecular Biology
|
American Society for Biochemistry and Molecular Biology
2 publications, 1.13%
|
|
Taylor & Francis
|
Taylor & Francis
2 publications, 1.13%
|
|
Hindawi Limited
|
Hindawi Limited
2 publications, 1.13%
|
|
American Association for Cancer Research (AACR)
|
American Association for Cancer Research (AACR)
2 publications, 1.13%
|
|
Spandidos Publications
|
Spandidos Publications
1 publication, 0.56%
|
|
Future Medicine
|
Future Medicine
1 publication, 0.56%
|
|
King Saud University
|
King Saud University
1 publication, 0.56%
|
|
The Korean Society of Genetics
|
The Korean Society of Genetics, 1, 0.56%
The Korean Society of Genetics
1 publication, 0.56%
|
|
Public Library of Science (PLoS)
|
Public Library of Science (PLoS)
1 publication, 0.56%
|
|
Federation of American Societies for Experimental Biology (FASEB)
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.56%
|
|
Biophysical Society
|
Biophysical Society
1 publication, 0.56%
|
|
Pleiades Publishing
|
Pleiades Publishing
1 publication, 0.56%
|
|
Oxford University Press
|
Oxford University Press
1 publication, 0.56%
|
|
Walter de Gruyter
|
Walter de Gruyter
1 publication, 0.56%
|
|
Proceedings of the National Academy of Sciences (PNAS)
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.56%
|
|
10
20
30
40
50
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023,2024],"ids":[0,0,0,0,0,0,0,0,0,0,0,0],"codes":[0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["","","","","","","","","","","",""],"datasets":[{"label":"Citations number","data":[6,9,19,17,15,20,16,19,23,15,16,2],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["3.39","5.08","10.73","9.6","8.47","11.3","9.04","10.73","12.99","8.47","9.04","1.13"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["International Journal of Molecular Sciences","European Journal of Medicinal Chemistry","Scientific Reports","Mitochondrion","Frontiers in Oncology","Cell Death and Disease","Biomedicine and Pharmacotherapy","ChemMedChem","Antioxidants and Redox Signaling","Biochemical Journal","Journal of Personalized Medicine","Biomedicines","Frontiers in Pharmacology","BioMetals","BMC Cancer","Journal of Controlled Release","Journal of Biological Chemistry","Bioorganic and Medicinal Chemistry Letters","Chemico-Biological Interactions","Biochimica et Biophysica Acta - Molecular Cell Research","Toxicology in Vitro","Biochimica et Biophysica Acta - Bioenergetics","Journal of Medicinal Chemistry","Advances in Experimental Medicine and Biology","Methods in Molecular Biology","Molecular Cancer Therapeutics","Archiv der Pharmazie","Antibiotics","Journal of Pharmacology and Experimental Therapeutics"],"ids":[14627,8171,13767,18142,10990,25236,23951,1430,5732,15459,2479,24421,9788,8167,6868,14351,19451,8828,15240,21133,19840,1512,3673,17590,3516,16265,15226,1488,21000],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/Zy5YST233rzRbZP24I24MzZm64hz20ZV9qQopmMn_medium.webp","\/storage\/images\/resized\/nUqNrP9GnM1t0BrAIXp1LBodjU8aIJ2Fk4pLfGhZ_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/OuA6WPZekwEiUM99mP2pSqj4yHPxHezM6xgLhAjO_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/cfuVw6XIq2mATDNJdXiose3W8qYbkmaVSpHoP8XL_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/s6JtNKPXrzklKtbQZ4HrtzuJT0P7eHPX9U8x0nss_medium.webp"],"datasets":[{"label":"","data":[13,9,6,4,3,3,3,3,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[7.34,5.08,3.39,2.26,1.69,1.69,1.69,1.69,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,1.13,0.56,0.56,0.56],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Elsevier","Springer Nature","Multidisciplinary Digital Publishing Institute (MDPI)","Wiley","American Chemical Society (ACS)","Frontiers Media S.A.","Royal Society of Chemistry (RSC)","Bentham Science","American Society for Pharmacology and Experimental Therapeutics","Mary Ann Liebert","Portland Press","American Society for Biochemistry and Molecular Biology","Taylor & Francis","Hindawi Limited","American Association for Cancer Research (AACR)","Spandidos Publications","Future Medicine","King Saud University","The Korean Society of Genetics","Public Library of Science (PLoS)","Federation of American Societies for Experimental Biology (FASEB)","Biophysical Society","Pleiades Publishing","Oxford University Press","Walter de Gruyter","Proceedings of the National Academy of Sciences (PNAS)"],"ids":[17,8,202,11,40,208,123,39,695,230,801,2090,18,6921,2286,1097,6949,171,1759,344,3243,1454,101,19,4,162],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp","\/storage\/images\/resized\/s6JtNKPXrzklKtbQZ4HrtzuJT0P7eHPX9U8x0nss_medium.webp","\/storage\/images\/resized\/Zy5YST233rzRbZP24I24MzZm64hz20ZV9qQopmMn_medium.webp","\/storage\/images\/resized\/nUqNrP9GnM1t0BrAIXp1LBodjU8aIJ2Fk4pLfGhZ_medium.webp","\/storage\/images\/resized\/OuA6WPZekwEiUM99mP2pSqj4yHPxHezM6xgLhAjO_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/hqfzhQAjTGlNSRs6yzFNITgjSMm9Jr2QuotJHIvE_medium.webp","\/storage\/images\/resized\/cfuVw6XIq2mATDNJdXiose3W8qYbkmaVSpHoP8XL_medium.webp","\/storage\/images\/resized\/8zKfOwdd5XirYzTQfqwp7U8IEQc8ckIOjyYQSBkk_medium.webp","\/storage\/images\/resized\/AN2jnDN59NmKaS4CWLHAGstADL2DbnatQScsFA6C_medium.webp","\/storage\/images\/resized\/9z7b0TQJNgUxZHYXLrTmbnjJn9y5iq56Wxtqb1Lv_medium.webp","","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/dfTCxFYwjmdhSAwAcIOV9PfBdAN17zTMvybxH2kG_medium.webp","\/storage\/images\/resized\/Bmz9XNb2QDptmPTa5N8huM54tShVewUj8fZqKFRy_medium.webp","\/storage\/images\/resized\/oZgeErrVFhuDksyqFURLvYS1wtVSBWczh001igGo_medium.webp","\/storage\/images\/resized\/yNSijlgQghQF53VZuyFLA30CKDe4j3HK74Vtpnxa_medium.webp","\/storage\/images\/resized\/3SpVxcYL33bOvPq4sHxJLH2NeKNeDloahSUpNiO4_medium.webp","\/storage\/images\/resized\/mxFdPe9qujsfvfYfcN0QOclAiYORFb0xrRlwV8gs_medium.webp"],"datasets":[{"label":"","data":[50,32,22,14,9,6,5,3,2,2,2,2,2,2,2,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[28.25,18.08,12.43,7.91,5.08,3.39,2.82,1.69,1.13,1.13,1.13,1.13,1.13,1.13,1.13,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Neuzil J. et al. Classification of mitocans, anti-cancer drugs acting on mitochondria // Mitochondrion. 2013. Vol. 13. No. 3. pp. 199-208.
GOST all authors (up to 50)
Copy
Neuzil J., Dong L., Rohlena J., Truksa J., Ralph S. E. Classification of mitocans, anti-cancer drugs acting on mitochondria // Mitochondrion. 2013. Vol. 13. No. 3. pp. 199-208.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.mito.2012.07.112
UR - https://doi.org/10.1016%2Fj.mito.2012.07.112
TI - Classification of mitocans, anti-cancer drugs acting on mitochondria
T2 - Mitochondrion
AU - Neuzil, Jiri
AU - Dong, Lan-Feng
AU - Rohlena, Jakub
AU - Truksa, Jaroslav
AU - Ralph, Stephen E.
PY - 2013
DA - 2013/05/01 00:00:00
PB - Elsevier
SP - 199-208
IS - 3
VL - 13
SN - 1567-7249
SN - 1872-8278
ER -
Cite this
BibTex
Copy
@article{2013_Neuzil,
author = {Jiri Neuzil and Lan-Feng Dong and Jakub Rohlena and Jaroslav Truksa and Stephen E. Ralph},
title = {Classification of mitocans, anti-cancer drugs acting on mitochondria},
journal = {Mitochondrion},
year = {2013},
volume = {13},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.1016%2Fj.mito.2012.07.112},
number = {3},
pages = {199--208},
doi = {10.1016/j.mito.2012.07.112}
}
Cite this
MLA
Copy
Neuzil, Jiri, et al. “Classification of mitocans, anti-cancer drugs acting on mitochondria.” Mitochondrion, vol. 13, no. 3, May. 2013, pp. 199-208. https://doi.org/10.1016%2Fj.mito.2012.07.112.